1. Alvir, J.M., Lieberman, J.A., Safferman, A.Z., Schwimmer, J.L. & Schaaf, J.A. (1993) Clozapine-induced agranulocytosis. Incidence and risk factors in the United States. N. Engl. J. Med., 329, 162-167.
2. American Diabetes Association (2014) Diagnosis and classification of diabetes mellitus. Diabetes Care, 37 Suppl 1, S81-90.
3. Appiani, F., Carroll, B.T., Munoz, C. & Trecco, J. (2011) Clozapine-induced weight loss? Ann. Clin. Psychiatry, 23, 225.
4. Asenjo Lobos, C., Komossa, K., Rummel-Kluge, C., Hunger, H., Schmid, F., Schwarz, S. & Leucht, S. (2010) Clozapine versus other atypical antipsychotics for schizophrenia. Cochrane Database Syst. Rev., CD006633.
5. American Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders (DSM-5®), American Psychiatric Association Publishing, USA.